Related Experiment Video
Updated: Jun 12, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Persistent p21 expression after Nutlin-3a removal is associated with senescence-like arrest in 4N cells
1Department of Anatomy and Cell Biology, Rush University Medical Center, Chicago, Illinois 60612, USA.
Abstract:
Nutlin-3a is a preclinical drug that stabilizes p53 by blocking the interaction between p53 and MDM2. In our previous study, Nutlin-3a promoted a tetraploid G(1) arrest in two p53 wild-type cell lines (HCT116 and U2OS), and both cell lines underwent endoreduplication after Nutlin-3a removal. Endoreduplication gave rise to stable tetraploid clones resistant to therapy-induced apoptosis. Prior knowledge of whether cells are susceptible to Nutlin-induced endoreduplication and therapy resistance could help direct Nutlin-3a-based therapies. In the present study, Nutlin-3a promoted a tetraploid G(1) arrest in multiple p53 wild-type cell lines. However, some cell lines underwent endoreduplication to relatively high extents after Nutlin-3a removal whereas other cell lines did not. The resistance to endoreduplication observed in some cell lines was associated with a prolonged 4N arrest after Nutlin-3a removal. Knockdown of either p53 or p21 immediately after Nutlin-3a removal could drive endoreduplication in otherwise resistant 4N cells. Finally, 4N-arrested cells retained persistent p21 expression; expressed senescence-associated beta-galactosidase; displayed an enlarged, flattened phenotype; and underwent a proliferation block that lasted at least 2 weeks after Nutlin-3a removal. These findings demonstrate that transient Nutlin-3a treatment can promote an apparently permanent proliferative block in 4N cells of certain cell lines associated with persistent p21 expression and resistance to endoreduplication.
Insights
Nutlin-3a causes cell cycle arrest, but not all cells undergo endoreduplication and become therapy resistant. Resistance is linked to prolonged 4N arrest, which can be overcome by targeting p53 or p21.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Therapeutics
Background:
- Nutlin-3a stabilizes p53 by inhibiting p53-MDM2 interaction.
- Previous studies showed Nutlin-3a induces tetraploid G1 arrest and endoreduplication in some cell lines, leading to therapy-resistant tetraploid clones.
- Understanding differential cellular responses to Nutlin-3a is crucial for optimizing its therapeutic application.
Purpose of the Study:
- To investigate the variability in Nutlin-3a-induced endoreduplication across different p53 wild-type cell lines.
- To identify mechanisms underlying resistance to endoreduplication following Nutlin-3a treatment.
- To characterize the long-term fate of cells arrested in the 4N state after Nutlin-3a removal.
Main Methods:
- Treatment of multiple p53 wild-type cell lines with Nutlin-3a.
- Assessment of endoreduplication extent after Nutlin-3a removal.
- Manipulation of p53 and p21 levels via knockdown in 4N-arrested cells.
- Analysis of cellular markers including p21 expression, senescence-associated beta-galactosidase, cell morphology, and proliferation.
Main Results:
- Nutlin-3a induced tetraploid G1 arrest in all tested cell lines, but endoreduplication varied significantly.
- Cell lines resistant to endoreduplication exhibited a prolonged 4N arrest.
- Knockdown of p53 or p21 rescued endoreduplication in resistant 4N cells.
- 4N-arrested cells displayed persistent p21 expression, senescence markers, and a sustained proliferation block.
Conclusions:
- Transient Nutlin-3a treatment can lead to a persistent proliferative block in a subset of 4N-arrested cells, independent of endoreduplication.
- This resistance is associated with sustained p21 expression and senescence.
- The findings highlight differential cellular responses to Nutlin-3a, impacting therapeutic resistance and suggesting novel targeting strategies.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Replicative Cell Senescence
Replicative Cell Senescence
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
